	Hybrid gabor attention convolution and transformer interaction network with hierarchical monitoring mechanism for liver and tumor segmentation. Sci Rep Wang Z, Fu S, Fu S, Li D, Liu D, Yao Y, Yin H, Bai L. PMID: 40064901 [PubMed - indexed for MEDLINE]
	New frontiers in hepatocellular carcinoma: Precision imaging for microvascular invasion prediction. World J Gastroenterol Hao L, Zhang ZN, Han S, Li SS, Lin SX, Miao YD. PMID: 40062334 [PubMed - indexed for MEDLINE]
	Progress in the Application of Novel Nanomaterials in Targeted Therapy for Liver Cancer. Int J Nanomedicine Wei X, Cao W, Wang S, Zhang Y, Gao Z, Wang S, Yao L, Zhang Z, Li X, Deng W, Xie Y, Li M. PMID: 40061885 [PubMed - indexed for MEDLINE]
	Flavonoids of Andrographis paniculata regulate hepatitis B virus replication and hepatocellular carcinoma progression: evidence from computational and experimental studies. BMC Complement Med Ther Patil VS, Harish DR, Charla R, Bhandare VV, Gujarathi SS, Beerwala FA, Patil PP, Jalalpure SS, Hegde HV, Roy S. PMID: 40057777 [PubMed - indexed for MEDLINE]
	Global, regional and national burden of liver cancer 1990-2021: a systematic analysis of the global burden of disease study 2021. BMC Public Health Jiang Z, Zeng G, Dai H, Bian Y, Wang L, Cao W, Yang J. PMID: 40057711 [PubMed - indexed for MEDLINE]
	Radiofrequency ablation versus stereotactic body radiotherapy for recurrent hepatocellular carcinoma: aÂ multicenter, propensity score matching analysis. BMC Cancer Ma ZH, Lin XL, Liu FH, Zhang JL, Yan ML, Song XC, Guo L, Xue J, Lu CD, Shi J, Meng Y, Cheng SQ, Guo WX. PMID: 40057688 [PubMed - indexed for MEDLINE]
	Efficacy and safety of postoperative adjuvant HAIC with FOLFOX combining PD-1 inhibitors in HCC patients with microvascular invasion: a propensity score matching analysis. BMC Cancer Liang Y, Zhong D, Shang J, Yan H, Su Y, Chen Y, Yang Q, Huang X. PMID: 40055613 [PubMed - indexed for MEDLINE]
	Development of a MVI associated HCC prognostic model through single cell transcriptomic analysis and 101 machine learning algorithms. Sci Rep Zhang J, Zhang Z, Yang C, Liu Q, Song T. PMID: 40055377 [PubMed - indexed for MEDLINE]
	Negative impact of chemotherapy on kinetic growth rate of the future liver remnant if applied following PVE or ALPPS. PLoS One Welcker K, Schneider MA, Reese T, Ehrenfeld A, Weilert H, Stang A, Wohlmuth P, Warnke MM, Reiner C, von Hahn T, Oldhafer KJ, Mahnken AH, Brüning R. PMID: 40053536 [PubMed - indexed for MEDLINE]
	Prognostic analysis and limited efficacy of adjuvant TACE in hepatocellular carcinoma following hepatectomy: a propensity score-matched study. Langenbecks Arch Surg Peng Y, Shen S, Feng Y, Wen Z, Qin J, Lu W, Xiang B. PMID: 40053156 [PubMed - indexed for MEDLINE]
	Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues. J Viral Hepat Inoue J, Minami S, Abe K, Kida M, Haga H, Iino C, Numao H, Kuroda H, Ninomiya M, Tsuruoka M, Sato K, Onuki M, Sawahashi S, Ouchi K, Watanabe K, Akahane T, Kobayashi T, Ohira H, Ueno Y, Masamune A. PMID: 40052685 [PubMed - indexed for MEDLINE]
	Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma. Front Immunol Yuan LX, Yue ZQ, Ma QR, Zhang P, Xiao F, Chen L. PMID: 40051634 [PubMed - indexed for MEDLINE]
	Cost-effectiveness of atezolizumab plus bevacizumab versus sorafenib as first-line therapy in unresectable hepatocellular carcinoma in the US and Chinese setting: a modelling comparison study. BMJ Open Liu L, Wang L, Ding Y, Zhang Q, Shu Y. PMID: 40050065 [PubMed - indexed for MEDLINE]
	Screening to identify people with type 2 diabetes at risk of liver cancer in primary care: a randomised controlled trial protocol. BMJ Open Buchanan RM, Reinson T, Bilson J, Woodland H, Nwoguh C, Cooper K, Harris S, Malone K, Byrne CD. PMID: 40050060 [PubMed - indexed for MEDLINE]
	Mono-TKI and TKI Plus ICI in Unresectable Hepatocellular Carcinoma Progression on First-Line Treatment of Lenvatinib: A Real-World Study. Cancer Med Yin X, Deng N, Chen J, Ding X. PMID: 40047078 [PubMed - indexed for MEDLINE]
	Biomarkers of hepatocellular carcinoma: status and prospects. Biomed Khim Zorina ES, Naryzhny SN. PMID: 40045719 [PubMed - indexed for MEDLINE]
	Hepatocellular carcinoma: Morphological spectrum and subtyping as per the World Health Organization classification on FNA biopsy with cell block samples. Cancer Cytopathol Dhiman B, Kundu R, Mitra S, Kalra N, Premkumar M, Duseja AK, Srinivasan R. PMID: 40045688 [PubMed - indexed for MEDLINE]
	Tumor burden score combined with AFP and PIVKA-II (TAP score) to predict the prognosis of hepatocellular carcinoma patients after radical liver resection. Langenbecks Arch Surg Qiu ZC, Wu YW, Dai JL, Qi WL, Chen CW, Xu YQ, Shen JY, Li C, Wen TF. PMID: 40045063 [PubMed - indexed for MEDLINE]
	Deep learning for hepatocellular carcinoma recurrence before and after liver transplantation: a multicenter cohort study. Sci Rep Cao S, Yu S, Huang L, Seery S, Xia Y, Zhao Y, Si Z, Zhang X, Zhu J, Lang R, Kou J, Zhang H, Wei L, Zhou G, Sun L, Wang L, Li T, He Q, Zhu Z. PMID: 40044774 [PubMed - indexed for MEDLINE]
	Hepatocellular Carcinoma Screening: From Current Standard of Care to Future Directions. J Am Coll Radiol Mohnasky M, Gad S, Moon A, Barritt AS, Charalel RA, Eckblad C, Caddell A, Xing M, Kokabi N. PMID: 40044304 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 71035

Page 1 of 3552



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy